Answers are grounded in this paper and cite their sources.
Background & Objective: Dangerous O is very important to transfusion medicine and there has been reports by Food and Drug Administration (FDA) regarding some death relating incidences. As high iso-antibody production is closely associated with different immune reactions, a survey on the different immune response of dangerous O donors can lead to understanding their immune response profile. Objectives were to assess different immune responses in dangerous O cases.
No takes yet. Share an insight, caveat, or question.
Arabi et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: